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Inherited cutis laxa is a connective tissue disorder characterized by loose skin and variable internal organ involve-
ment, resulting from paucity of elastic fibers. Elsewhere, frameshift mutations in the elastin gene have been reported
in three families with autosomal dominant inheritance, and a family with autosomal recessive cutis laxa was recently
reported to have a homozygous missense mutation in the fibulin-5 gene. In the present study, we analyzed the gene
expression of elastin and fibulins 1–5 in fibroblasts from five patients with cutis laxa. One patient was found to
express both normal (2.2 kb) and mutant (2.7 kb) fibulin-5 mRNA transcripts. The larger transcript contains an
internal duplication of 483 nucleotides, which resulted in the synthesis and secretion of a mutant fibulin-5 protein
with four additional tandem calcium-binding epidermal growth factor–like motifs. The mutation arose from a 22-
kb tandem gene duplication, encompassing the sequence from intron 4 to exon 9. No fibulin-5 or elastin mutations
were detected in the other patients. The results demonstrate that a heterozygous mutation in fibulin-5 can cause
cutis laxa and also suggest that fibulin-5 and elastin gene mutations are not the exclusive cause of the disease.
Cutis laxa (MIM 123700; MIM 219100) comprises a
heterogeneous group of inherited and acquired disorders
characterized by loose, sagging, and redundant skin,
which often leads to an appearance of premature aging
(Uitto and Pulkkinen 2002). A characteristic histopath-
ological abnormality is the fragmentation and paucity
of elastic fibers in the skin (Hashimoto and Kanzaki
1975; Kitano et al. 1989). Congenital cutis laxa may be
inherited in an autosomal dominant or autosomal re-
cessive pattern (Agha et al. 1978). In the recessive form
of the disease, the skin changes are often accompanied
by abnormalities in internal organs that are enriched in
elastic fibers, such as emphysematous lungs and tortuous
arteries. The internal organ involvement is less frequently
observed in autosomal dominant cutis laxa.
Reduced elastin mRNA levels have been shown else-
where in skin fibroblasts from patients with cutis laxa
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(Olsen et al. 1988), and frameshift mutations in the 3′
end of the elastin gene have subsequently been found in
three families with autosomal dominant inheritance (Tas-
sabehji et al. 1998; Zhang et al. 1999). The molecular
defects underlying the recessive forms of cutis laxa re-
mained obscure until recently, when two groups of in-
vestigators independently showed that mice lacking fi-
bulin-5 developed loose skin, lung emphysema, and
vascular abnormalities reminiscent of patients with cutis
laxa (Nakamura et al. 2002; Yanagisawa et al. 2002).
This led to subsequent identification of a homozygous
missense mutation in fibulin-5 in a large consanguineous
Turkish family with autosomal recessive cutis laxa and
pulmonary emphysema (Loeys et al. 2002).
Fibulin-5, also known as EVEC or DANCE, is a 66-
kDa secreted protein identified through its abundant ex-
pression in developing and injured arteries (Kowal et al.
1999; Nakamura et al. 1999). The fibulin family mem-
bers share a common C-terminal globular domain pre-
ceded by tandem arrays of calcium-binding epidermal
growth factor–like (cbEGF) motifs (Argraves et al. 1990;
Pan et al. 1993; Lecka-Czernik et al. 1995; Giltay et al.
1999). Fibulins-1, -2, -4, and -5 are predominantly ex-
pressed in tissues rich in elastic fibers, including arteries,
cardiac valves, lungs, and skin (Zhang et al. 1995, 1996;
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Figure 1 Northern blot analysis of gene expression in fibroblasts
from patients with cutis laxa. All fibroblast cultures were derived from
skin tissue except for the culture from patient CL-2, which was es-
tablished from lung tissue. Fibroblasts from patient CL-7 (GM02768)
were obtained from Coriell Cell Repositories. Control dermal and lung
fibroblasts were cultured from clinically normal individuals. Fibroblasts
were grown in Dulbecco’s modified Eagle medium with 10% fetal
bovine serum at 37 C in 5% CO2. The fibroblast cultures were ex-
amined at passage 4–7 except for CL-7, which was examined at pas-
sage 11–13. Total RNA (10 mg) from fibroblasts of the control subjects
and patients CL-2–CL-8 was transferred to Duralon-UV membrane
(Stratagene) and hybridized sequentially with a-[32P]dCTP–labeled
cDNA probes for fibulin-5, fibulin-4, elastin, fibulin-3, fibulin-2, fi-
bulin-1, and b-actin, in that order. The cDNA probes were generated
by RT-PCR. The sizes of the transcripts are indicated on the right.
Arrows highlight qualitative and quantitative changes of gene expres-
sion (see text).
Giltay et al. 1999; Kowal et al. 1999; Nakamura et al.
1999). In addition, fibulin-1, -2, and -5 have been lo-
calized to elastic fibers. However, their precise distri-
bution within the elastic fibers—and, hence, their mo-
lecular interactions—are somewhat different. Human
disorders previously associated with the fibulin family
include two types of retinal dystrophy, resulting from a
single mutation in fibulin-3/EFEMP1 (Stone et al. 1999),
and a complex synpolydactyly, associated with a chro-
mosomal translocation disrupting the fibulin-1 locus
(Debeer et al. 2002).
The similarity in primary structure and expression
pattern of the fibulin family members suggest that, in
addition to fibulin-5, other fibulins may contribute to
the abnormal phenotypes of cutis laxa. We therefore
analyzed the gene expression of the fibulin family and
elastin in fibroblasts from five patients with sporadic
cutis laxa. An affected mother (CL-6) and her son (CL-
8), in a family with dominant cutis laxa and a single-
nucleotide deletion in exon 30 of the elastin gene (Zhang
et al. 1999), were included in the analysis. The patients
were all given the diagnosis of cutis laxa on the basis of
the characteristic cutaneous findings, including loose and
sagging skin with reduced recoil. The diagnosis was con-
firmed by histopathology with elastin-specific stains (Ver-
hoeff-van Gieson or Orcein), which showed paucity or
fragmentation of elastic fibers.
Patient CL-5, an African American female, had ex-
tensive folding and redundant skin on the abdominal
area and the arms when she was initially seen shortly
after birth. No clinical signs of internal organ involve-
ment were noted. However, cardiovascular evaluation
by echocardiography and electrocardiography revealed
mitral valve regurgitation. Family history was negative
for similar clinical conditions. The parents were in good
health, and the patient had no siblings. Patient CL-5 was
reexamined at age 11 years and was noted to have slightly
hyperextensible skin, which demonstrated wrinkling on
the backs of hands and wrists, and slightly accentuated
excessive skin folds on the abdomen. The patient has
recently been diagnosed with scoliosis (12 degrees). Echo-
cardiography, repeated at 2-year intervals, has continued
to detect mitral valve regurgitation, whereas the diam-
eter of aorta is normal with no evidence of aneurysms.
In summary, the patient has cutis laxa with mild car-
diovascular involvement, but the cutaneous manifesta-
tions have significantly improved over the 1st decade of
life.
Total RNA isolated from fibroblast cultures of pa-
tients afflicted with cutis laxa was first examined for the
expression of the fibulin-5 mRNA. Northern blot hy-
bridization showed that all patients expressed the 2.2-
kb fibulin-5 transcript; however, an additional 2.7-kb
mRNA was present in patient CL-5 (fig. 1). The ex-
pression of elastin and the other members of the fibulin
family was subsequently analyzed by rehybridizing the
same nylon membrane consecutively with various probes.
Although the transcript levels of fibulin-1 through fi-
bulin-4 and elastin were somewhat variable among fi-
broblast strains, substantial quantitative differences were
noted in several samples. Specifically, the fibulin-2 tran-
script was not detectable in patient CL-2 fibroblasts de-
rived from lung (fig. 1), yet control lung fibroblasts (not
shown) clearly contained this transcript. In addition, both
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Figure 2 Schematic diagram of normal and mutant fibulin-5 proteins and genes. A, top, Human fibulin-5 protein consists of 448 amino
acids, including a signal peptide (SP) of 23 residues at the N-terminus, six tandem cbEGF motifs (domain II, a–f), and a C-terminal globular
domain (domain III) of 134 amino acids. The first cbEGF motif (IIa) is atypical, as it contains an unusually long linker sequence of 28 amino
acids between the 4th and 5th cysteine residues. An RGD sequence is present in the first cbEGF domain. The locations of three primer pairs
(1F/1R, 2F/2R, and 3F/3R) used for RT-PCR amplification of the fibulin-5 transcript are indicated. Bottom, The fibulin-5 gene, consisting of
11 exons spanning 80 kb of DNA on human chromosome 14. The six cbEGF motifs are each encoded by a single exon (exons 4–9). Exons 1
and 2 encode the signal peptide, exon 3 encodes a partial cbEGF motif, and exons 10 and 11 encode the C-terminal globular domain. A large
intron of 42 kb separates exons 4 and 5, which encode the first and second cbEGF motifs. B, top, The mutant fibulin-5 protein with a tandem
duplication of four cbEGF motifs, IIb–IIe (shaded). Bottom, The mutant allele from patient CL-5 containing a tandem gene duplication of 22
kb, extending from intron 4 to exon 9.
patient CL-2 and patient CL-5 expressed significantly
reduced levels of the elastin mRNA.
Human fibulin-5 consists of 448 amino acids, includ-
ing a signal peptide of 23 residues at the N-terminus,
six tandem cbEGFmotifs (IIa–IIf), and a C-terminal glob-
ular domain common to all fibulins (fig. 2A). The entire
fibulin-5 coding region of 1.4 kb in all five patients was
amplified by RT-PCR with three primer pairs (fig. 2A)
and then was subjected to DNA sequencing. The primer
pairs were 1F (CAAGCTTTCTTCTCGCCTTC) and 1R
(GCCAATATCCGTCGGTGCAG), 2F (TGGACGAG-
TGTGCAACAGAT) and 2R (TGTGCTCACATTCGT-
TGATG), and 3F (CGGCACATACTTCTGCTCCT) and
3R (TCAGAATGGGTACTGCGACA). In patient CL-5,
the three primer pairs each amplified the expected prod-
uct and an additional product ∼500 bp longer (data not
shown). Combination of DNA sequencing and use of
allele-specific primers 3F and 660R (GCCTTCCAGAA-
GCCAATATC) revealed that the larger transcript in CL-
5 contained a tandem duplication of 483 bp, corre-
sponding to cbEGF motifs IIb–IIe encoded by exons 5–8
of the fibulin-5 gene (fig. 2B; fig. 3).
Genomic DNA from patient CL-5 and the control
subjects was digested with EcoRI, BamHI, and HindIII
and analyzed by Southern blot hybridization, using a
full-length fibulin-5 cDNA as the probe. The hybridi-
zation pattern of patient CL-5 was similar to that of the
control subjects except for the presence of two additional
Figure 3 DNA sequence analysis of the fibulin-5 mutation in patient CL-5. A, Sequence of the duplication boundary in the fibulin-5
mRNA. RT-PCR amplification of total RNA from patient CL-5, with primers 3F and 660R (see fig. 2B), generated a 333-bp mutant-specific
product, which was sequenced with the primer 3F. Sequencing showed that nucleotide 852 in the fibulin-5 transcript was followed by nucleotide
369, corresponding to the joining exon 8 and exon 5. DNA and amino acid sequences of the mutant fibulin-5 and the corresponding regions
of the normal fibulin-5 are shown. Arrow and arrowheads mark the exon boarders. B, Sequence of the duplication boundary in the fibulin-5
gene. PCR amplification of genomic DNA from patient CL-5 with primers 3F and 660R (fig. 2B) yielded an 11-kb product, which was cloned
and sequenced with primer I8F3 (TCCGTAGTAGTGCCAGGCAA). Sequencing showed that, following nine nucleotides from the beginning
of exon 9, there is the sequence of intron 4 at 9,063 nucleotides upstream of exon 5. Sequences of the mutant allele, and the corresponding
regions of the normal allele in intron 8/exon 9 and intron 4, are aligned (E9 p exon 9; I4 p intron 4; I8 p intron 8). Exon sequences are
shown in uppercase letters, and intron sequences are shown in lowercase letters. The box depicts the 3-bp sequence that is identical between
exon 9 and intron 4, where the recombination occurred. The box with dotted lines shows that the nucleotide identity extends an additional 4
bp if a single-nucleotide gap in intron 4 is introduced.
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Figure 4 Analysis of the mutant fibulin-5 protein in patient
CL-5. A, In vitro transcription/translation. The full-length normal and
mutant fibulin-5 cDNAs were RT-PCR amplified, using Turbo pfu
polymerase (Stratagene), with 1F/3R primers, and cloned into the
pcDNA3 expression vector downstream of the T7 promoter. The ex-
pression vectors were subjected to coupled in vitro transcription/trans-
lation using the TNT Coupled Reticulocyte Lysate System (Promega)
in the presence of fluorescent lysyl-tRNA (FluoroTect GreenLys, Pro-
mega). The resulting products were separated on a 7.5% polyacryl-
amide gel and detected by a FluorImager. Translation of the normal
(lane 1) and mutant (lane 2) fibulin-5 constructs resulted in 60- and
80-kDa proteins, respectively, whereas translation of an expression
construct of normal fibulin-5 in the opposite orientation yielded no
product (lane 3). B, Immunoprecipitation. Fibroblasts were metabol-
ically labeled with [35S]cysteine (ICN Biochemicals) overnight in se-
rum-free medium, and culture medium (1 ml) from patient CL-5 (lane
1) and the control subjects (lane 2) was immunoprecipitated with an
affinity-purified antibody against fibulin-5, following the procedure
described elsewhere (Gra¨ssel et al. 1996). The rabbit antiserum was
raised from recombinant fibulin-5 protein expressed in 293-EBNA
cells, using the pCEP-Pu vector as described elsewhere (Giltay et al.
1999). The antibody was affinity purified on the antigen-coupled Se-
pharose 4B (Timpl 1982). The immunoprecipitated products were
separated on a 7.5% polyacrylamide gel and were detected with a
PhosphorImager.
fragments, 7-kbHindIII and 3-kbBamHI bands (data not
shown). This suggested the presence of DNA rearrange-
ment in one of the fibulin-5 alleles of patient CL-5. To
delineate the precise breakpoint of the gene duplication,
long-range PCR amplification of genomic DNAwas per-
formed using primer 3F, located in exon 8, and primer
660R, located in exon 5 (fig. 2B). An 11-kb product was
obtained, and DNA sequencing of the fragment revealed
that the duplication joined sequences of exon 9 (at 10
bp from the 5′ end of the exon) and intron 4 (at 9,063
bp from the 3′ end of intron) (fig. 3B; recombination of
nucleotides 26060245 and 26037516 in GenBank ac-
cession number NT_026437.8). The junction sequence
was within a 3-bp sequence that is identical between
exon 9 and intron 4 (fig. 3B). When a single-nucleotide
gap was introduced in intron 4, the sequence identity
extended another 4 bp. The result establishes that the
mutant allele contains a tandem duplication of 22,729
bp, extending from intron 4 to exon 9 (fig. 2B).
Genomic DNA from the mother of patient CL-5 was
analyzed by PCR, using primers flanking the boundary
of gene duplication. A 295-bp product specific for the
mutant allele was amplified from the genomic DNA of
patient CL-5, as expected, but not from the genomicDNA
of the mother (data not shown), indicating that the
mother does not carry the gene duplication. DNA from
the father of patient CL-5 was not available for analysis.
Sequence analysis of the fibulin-5 mRNA in the other
four patients revealed no deviations from the normal
control, except for a silent C/T polymorphism at nucleo-
tide 944. To rule out the possibility that only one allele
is expressed, each of the 11 exons and the flanking intron
sequences in the fibulin-5 gene in all five patients were
amplified by PCR from genomic DNA and analyzed by
denaturing high-performance liquid chromatography and
DNA sequencing. No mutations in the sequences of the
coding regions and splice junctions were detected (results
not shown). Furthermore, sequence analyses of the elas-
tin transcripts in all five patients showed no deviations
from the normal sequence.
To investigate the molecular mechanism underlying
the absence of fibulin-2 expression in patient CL-2, the
17 protein-coding exons, with ∼50–150 bp of the flank-
ing intron sequences and 1.0 kb proximal fibulin-2 pro-
moter region, were amplified by PCR from the genomic
DNA and then subjected to DNA sequencing. No mu-
tations in the exons and splice junction sequences were
detected. Southern blot analysis of genomic DNA from
patient CL-2, with the full-length cDNA probe, revealed
no DNA rearrangement.
The coding regions of the normal and mutant fibulin-
5 transcripts in patient CL-5 were prepared by RT-PCR
and cloned into the expression vector pCDNA3 down-
stream of the T7 promoter. The expression constructs
were subjected to coupled in vitro transcription/trans-
lation. As predicted by the DNA sequences, the normal
transcript yielded a 60-kDa translational product,
whereas the mutant transcript resulted in a larger prod-
uct of 80 kDa (fig. 4A).
To examine the synthesis and secretion of the mutant
fibulin-5, fibroblasts from patient CL-5 and the control
subjects were metabolically labeled overnight and the
culture media were immunoprecipitated with an affinity
purified polyclonal antibody against fibulin-5. Analysis
of the resultant products, by polyacrylamide gel elec-
trophoresis, revealed that patient CL-5 secreted both a
larger 85-kDa fibulin-5 protein and the normal 65-kDa
fibulin-5 protein (fig. 4B). By contrast, only a single 65-
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kDa normal fibulin-5 protein was observed in the con-
trol subjects. The sizes of the immunoprecipitated prod-
ucts were somewhat larger than those of their in vitro
translated counterparts, apparently owing to posttrans-
lational modifications. The antibody also precipitated a
220-kDa protein of unknown identity, which was pre-
sent in substantially higher amount in the patient, as
compared with the control subjects (fig. 4B).
Our finding that a heterozygous mutation results in
cutis laxa differs from the first fibulin-5 mutation recently
reported in the Turkish family (Loeys et al. 2002). Patients
who carry the homozygous missense mutation in the
Turkish family have severe cutis laxa phenotypes, with
internal organ involvement. However, family members
heterozygous for the mutation are not affected. The mis-
sense mutation is a leucine-to-proline substitution in the
fourth cbEGF motif. A similar amino acid substitution
in the cbEGF motifs of fibrillin-1 has been shown else-
where to interfere with protein folding (Wu et al. 1995).
This suggests that the missense fibulin-5 protein in the
Turkish family may be unstable, and, therefore, the
amount of the mutant protein present in the heterozygous
carriers might be too low, relative to its normal coun-
terpart, to exert a dominant negative effect. By contrast,
the larger fibulin-5 protein in patient CL-5 is stable, as
evidenced by the biosynthetic study and, thus, can act in
a dominant negative fashion.
The fibulin-5 mutation in patient CL-5 arose from an
internal gene duplication of 22 kb, and the chromosomal
recombination occurred within a 3-bp sequence that is
identical between exon 9 and intron 4. There are several
Alu-repetitive sequences within the 42-kb intron 4 and
one Alu sequence in the 2-kb intron 8, but these repeti-
tive sequences do not play a direct role in the gene du-
plication. The duplicated region consists of four complete
exons (exons 5–8), as well as a truncated exon 9 of only
9 bp, which contains an intact splice-acceptor site at the
5′ end but not the splice-donor site at the 3′ end. The
truncated exon-9 sequence, although it has an intact
splice-acceptor site, is skipped during the pre-mRNA–
processing step. The tandem gene duplication appears
to have an effect on transcription/processing/stability of
the mutant fibulin-5 mRNA, because quantification of
the northern blot in figure 1 indicates that the mutant
mRNA is present at a level 2.1-fold of the normal fibulin-
5 mRNA. Consistent with the increase in the mutant
fibulin-5 mRNA, quantification of the immunoprecipi-
tation result (fig. 4B) revealed that the mutant fibulin-5
protein is 1.4-fold of the normal counterpart.
In conclusion, our studies provide the first evidence
that a heterozygous mutation in the fibulin-5 gene can
result in cutis laxa, and they also suggest that mutations
in fibulin-5 and elastin are not the exclusive causes of
the disease.
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